Cartilago Argentum Joint Support

Manufacturer: Uriel Pharmacy Inc
Effective date: 2009-12-31
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-06-01 02:02:07

Label at a glance#

ProductCartilago Argentum Joint Support

Active ingredientMANDRAGORA OFFICINARUM ROOT, BETULA PENDULA LEAF, ACONITUM NAPELLUS ROOT, ARNICA MONTANA, SILVER

Label structure10 sections

Contacts and useful links#

PhoneLabel contact866 642-2858

Websitewww.urielpharmacy.com

www.urielpharmacy.com

Label contents#

Full prescribing information#

Purpose

OTC - PURPOSE SECTION

Uses: Temporarily relieves symptoms of aches and pains in joints.

Dosage & Administration

DOSAGE & ADMINISTRATION SECTION

Directions: Dissolve under tongue 3-4 times daily. Age 12 and older: 10 pellets. Ages 2-11: 5 pellets. Under age 2: ask a doctor.

OTC-Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients: Betula e fol. 5x, Mandragora off. e rad. 5X, Aconitum e tub. 6X, Arnica e pl. tota 6X, Argentum metallicum 8X, all HPUS.

Inactive Ingredient

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Sucrose, Antimonite 6X, Cartilago articularis 6X.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN.

Do not use section

OTC - DO NOT USE SECTION

Warnings: Do not use if allergic to any ingredient. Do not use if safety seal is broken or missing.

Ask doctor section

OTC - ASK DOCTOR SECTION

Consult a doctor if symptoms are serious or persist for 3 days, if you are diabetic or intolerant of sugar.

Pregnancy or breast feeding section

OTC - PREGNANCY OR BREAST FEEDING SECTION

If you are pregnant or nursing, consult a doctor before use.

Questions section

OTC - QUESTIONS SECTION

Questions? Uriel Pharmacy

866 642-2858 East Troy, WI 53120

www.urielpharmacy.com

NDC 48951-3037-2

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Cartilago Argentum

Joint Support

Homeopathic Pellets

net wt. 1 oz.

cartilago argentum pellets bottle label

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
48951-3037-2	2020-01-31	C162847	48780-1	9d75b9d0-83b3-f424-e053-dadaa90a57ce	Cartilago Argentum Joint Support Pellets - 1 oz.

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
48951-3037-2	Cartilago Argentum Joint Support	1350 in 1 BOTTLE, GLASS	PELLET	1350		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
48951-3037	CARTILAGO ARGENTUM JOINT SUPPORT (MANDRAGORA OFFICINARUM ROOT BETULA PENDULA LEAF ACONITUM NAPELLUS ROOT ARNICA MONTANA SILVER) PELLET [URIEL PHARMACY INC]	1	Legacy NDC, 1 package rows	20100101_50aa0150-f632-11de-8a39-0800200c9a66.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ACONITUM NAPELLUS ROOT	ACTIVE INGREDIENT	KPD2N7348X	1
ARNICA MONTANA	ACTIVE INGREDIENT	O80TY208ZW	1
BETULA PENDULA LEAF	ACTIVE INGREDIENT	5HW39H9KDH	1
MANDRAGORA OFFICINARUM ROOT	ACTIVE INGREDIENT	I2XCB174VB	1
SILVER	ACTIVE INGREDIENT	3M4G523W1G	1
ACONITUM NAPELLUS ROOT	ACTIVE MOIETY	KPD2N7348X	1
ARNICA MONTANA	ACTIVE MOIETY	O80TY208ZW	1
BETULA PENDULA LEAF	ACTIVE MOIETY	5HW39H9KDH	1
MANDRAGORA OFFICINARUM ROOT	ACTIVE MOIETY	I2XCB174VB	1
SILVER	ACTIVE MOIETY	3M4G523W1G	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

Cartilago Argentum Joint Support
MANDRAGORA OFFICINARUM ROOT BETULA PENDULA LEAF ACONITUM NAPELLUS ROOT ARNICA MONTANA SILVER
MANDRAGORA OFFICINARUM ROOT
BETULA PENDULA LEAF
SUCROSE
ACONITUM NAPELLUS ROOT
ARNICA MONTANA
SILVER

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
48951-3037	48951-3037-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
MANDRAGORA OFFICINARUM ROOT	I2XCB174VB	ACTIB
BETULA PENDULA LEAF	5HW39H9KDH	ACTIB
SUCROSE	C151H8M554	IACT
ACONITUM NAPELLUS ROOT	KPD2N7348X	ACTIB
ARNICA MONTANA	O80TY208ZW	ACTIB
SILVER	3M4G523W1G	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / INTRAVENOUS		1950 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTABLE, LIPOSOMAL / INTRAVENOUS		7560 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
36181840-f632-11de-8a39-0800200c9a66			50aa0150-f632-11de-8a39-0800200c9a66	2009-12-31		Exact identifier spl id: 36181840-f632-11de-8a39-0800200c9a66 spl set id: 50aa0150-f632-11de-8a39-0800200c9a66

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.